Surgical outcomes and prognostic factors for patients with gastric cancer spinal metastasis

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• In H, Solsky I, Palis B, Langdon-Embry M, Ajani J, Sano T. Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the national cancer database. Ann Surg Oncol. 2017;24(12):3683–3691. doi:10.1245/s10434-017-6078-x28895113
   PubMed Web of Science ®Google Scholar
• Park HS, Rha SY, Kim HS, et al. A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis. Oncology. 2011;80(1–2):142–150. doi:10.1159/00032850721677462
   PubMed Web of Science ®Google Scholar
• Ahn JB, Ha TK, Kwon SJ. Bone metastasis in gastric cancer patients. J Gastric Cancer. 2011;11(1):38–45. doi:10.5230/jgc.2011.11.1.3822076200
   PubMedGoogle Scholar
• Silvestris N, Pantano F, Ibrahim T, et al. Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey. Plos One. 2013;8(10):e74402. doi:10.1371/journal.pone.007440224204569
   PubMed Web of Science ®Google Scholar
• Turkoz FP, Solak M, Kilickap S, et al. Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival. J Gastric Cancer. 2014;14(3):164–172. doi:10.5230/jgc.2014.14.3.16425328761
   PubMedGoogle Scholar
• Qiu MZ, Shi SM, Chen ZH, et al. Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: a SEER-based study. Cancer Med. 2018. doi:10.1002/cam4.1661
   Web of Science ®Google Scholar
• Mikami J, Kimura Y, Makari Y, et al. Clinical outcomes and prognostic factors for gastric cancer patients with bone metastasis. World J Surg Oncol. 2017;15(1):8. doi:10.1186/s12957-016-1091-228061855
   PubMedGoogle Scholar
• Nakamura K, Tomioku M, Nabeshima K, Yasuda S. Clinicopathologic features and clinical outcomes of gastric cancer patients with bone metastasis. Tokai J Exp Clin Med. 2014;39(4):193–198.25504207
   PubMedGoogle Scholar
• Choi YJ, Kim DH, Han HS, et al. Long-term survival after gastrectomy and metastasectomy for gastric cancer with synchronous bone metastasis. World J Gastroenterol. 2018;24(1):150–156. doi:10.3748/wjg.v24.i1.15029358891
   PubMed Web of Science ®Google Scholar
• Lee J, Lim T, Uhm JE, et al. Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma. Ann Oncol. 2007;18(5):886–891. doi:10.1093/annonc/mdl50117298958
   PubMed Web of Science ®Google Scholar
• Choi D, Crockard A, Bunger C, et al. Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group. Eur Spine J. 2010;19(2):215–222. doi:10.1007/s00586-009-1252-x20039084
   PubMed Web of Science ®Google Scholar
• Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–655. doi:10.1097/00000421-198212000-000147165009
   PubMed Web of Science ®Google Scholar
• Klimo PJ, Thompson CJ, Kestle JR, Schmidt MH. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro Oncol. 2005;7(1):64–76. doi:10.1215/S115285170400026215701283
   PubMed Web of Science ®Google Scholar
• Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366(9486):643–648. doi:10.1016/S0140-6736(05)66954-116112300
   PubMed Web of Science ®Google Scholar
• Chong S, Shin SH, Yoo H, et al. Single-stage posterior decompression and stabilization for metastasis of the thoracic spine: prognostic factors for functional outcome and patients’ survival. Spine J. 2012;12(12):1083–1092. doi:10.1016/j.spinee.2012.10.01523168136
   PubMed Web of Science ®Google Scholar
• Demura S, Kawahara N, Murakami H, et al. Total en bloc spondylectomy for spinal metastases in thyroid carcinoma. J Neurosurg Spine. 2011;14(2):172–176. doi:10.3171/2010.9.SPINE0987821184643
   PubMed Web of Science ®Google Scholar
• Yang X, Wu Z, Xiao J, et al. Chondrosarcomas of the cervical and cervicothoracic spine: surgical management and long-term clinical outcome. J Spinal Disord Tech. 2012;25(1):1–9. doi:10.1097/BSD.0b013e31820bb08522143043
   PubMedGoogle Scholar
• Jia Q, Yin H, Yang J, et al. Treatment and outcome of metastatic paraganglioma of the spine. Eur Spine J. 2018;27(4):859–867. doi:10.1007/s00586-017-5140-528653097
   PubMed Web of Science ®Google Scholar
• Domenicucci M, Nigro L, Delfini R. Total en-bloc spondylectomy through a posterior approach: technique and surgical outcome in thoracic metastases. Acta Neurochir (Wien). 2018;160(7):1373–1376. doi:10.1007/s00701-018-3572-229808457
   PubMed Web of Science ®Google Scholar
• Park JH, Hyun SJ, Kim KJ, Jahng TA. Total en bloc thoracic and lumbar spondylectomy for non-small cell lung cancer with favorable prognostic indicators: is it merely indicated for solitary spinal metastasis? J Korean Neurosurg Soc. 2014;56(5):431–435. doi:10.3340/jkns.2014.56.5.43125535523
   PubMed Web of Science ®Google Scholar
• Roedel B, Clarencon F, Touraine S, et al. Has the percutaneous vertebroplasty a role to prevent progression or local recurrence in spinal metastases of breast cancer? J Neuroradiol. 2015;42(4):222–228. doi:10.1016/j.neurad.2014.02.00424998599
   PubMed Web of Science ®Google Scholar
• Tocchi A, Costa G, Lepre L, et al. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. J Cancer Res Clin Oncol. 1998;124(8):450–455.9750022
   PubMed Web of Science ®Google Scholar
• Tachibana M, Takemoto Y, Nakashima Y, et al. Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer. J Am Coll Surg. 1998;187(1):64–68.9660027
   PubMed Web of Science ®Google Scholar
• Ychou M, Duffour J, Kramar A, Gourgou S, Grenier J. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Dis Markers. 2000;16(3–4):105–110. doi:10.1155/2000/59549211381189
   PubMed Web of Science ®Google Scholar
• Ishigami S, Natsugoe S, Hokita S, et al. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol. 2001;32(1):41–44.11154168
   PubMed Web of Science ®Google Scholar
• Deng K, Yang L, Hu B, Wu H, Zhu H, Tang C. The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patients. Plos One. 2015;10(4):e124151.
   Web of Science ®Google Scholar
• Sun X, Sun Z, Zhu Z, et al. Clinicopathological significance and prognostic value of lactate dehydrogenase A expression in gastric cancer patients. Plos One. 2014;9(3):e91068. doi:10.1371/journal.pone.009106824608789
   PubMed Web of Science ®Google Scholar
• Li G, Gao J, Tao YL, et al. Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma. Chin J Cancer. 2012;31(4):197–206. doi:10.5732/cjc.011.1028322237040
   PubMedGoogle Scholar
• Han J, Yong B, Luo C, Tan P, Peng T, Shen J. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China. World J Surg Oncol. 2012;10:37. doi:10.1186/1477-7819-10-19822333159
   PubMed Web of Science ®Google Scholar
• Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976). 2005;30(19):2186–2191.16205345
   PubMed Web of Science ®Google Scholar
• Yoshikawa K, Kitaoka H. Bone metastasis of gastric cancer. Jpn J Surg. 1983;13(3):173–176.6632389
   PubMedGoogle Scholar
• Murai N, Koga K, Nagamachi S, et al. Radiotherapy in bone metastases–with special reference to its effect on relieving pain. Gan No Rinsho. 1989;35(10):1149–1152.2550686
   PubMedGoogle Scholar
• Rades D, Lange M, Veninga T, et al. Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys. 2011;79(2):524–530. doi:10.1016/j.ijrobp.2009.10.07320452136
   PubMed Web of Science ®Google Scholar
• Laufer I, Rubin DG, Lis E, et al. The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist. 2013;18(6):744–751. doi:10.1634/theoncologist.2012-029323709750
   PubMed Web of Science ®Google Scholar
• Wang HJ, Liu Y, Fan LQ, et al. A new bisphosphonate derivative, CP, induces gastric cancer cell apoptosis via activation of the ERK1/2 signaling pathway. Acta Pharmacol Sin. 2013;34(12):1535–1544. doi:10.1038/aps.2013.10324241351
   PubMed Web of Science ®Google Scholar
• Yang H, Qiu L, Zhang L, et al. Platinum-zoledronate complex blocks gastric cancer cell proliferation by inducing cell cycle arrest and apoptosis. Tumour Biol. 2016;37(8):10981–10992. doi:10.1007/s13277-016-4977-226891667
   PubMedGoogle Scholar